Semaglutide Brand names: Ozempic (diabetes), Wegovy (weight management) Semaglutide was the first GLP-1 receptor agonist to gain widespread adoption for weight management
Eur J Pharm Biopharm 177:5060 Beig A, Ackermann R, Wang Y, Schutzman R, Schwendeman SP (2022) Minimizing the initial burst of octreotide acetate from glucose star PLGA microspheres prepared by the solvent evaporation method
The GIPR pathway particularly enhances insulin secretion and glucose handling, supporting faster metabolic adaptation during calorie reduction
Appetite and Digestion Effects Wegovy mimics GLP-1 hormones that signal fullness to the brain and slow digestion
Balanced meals, protein, fiber, and regular eating patterns can improve results and make weight loss more sustainable